Trial · NCT02534844
Results by group88
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 88
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Parts A/B: Change From Baseline to Week 52 in 4-Item Composite Score of Niemann Pick Type C Severity Scale (NPC-SS) Score | Sham Control | Baseline | 8.1 | Standard Deviation 4.27 | score on a scale |
| Parts A/B: Change From Baseline to Week 52 in 4-Item Composite Score of Niemann Pick Type C Severity Scale (NPC-SS) Score | Adrabetadex | Baseline | 8.8 | Standard Deviation 3.12 | score on a scale |
| Parts A/B: Change From Baseline to Week 52 in 4-Item Composite Score of Niemann Pick Type C Severity Scale (NPC-SS) Score | Sham Control | Change from Baseline at Week 52 | -0.1 | Standard Deviation 1.55 | score on a scale |
| Parts A/B: Change From Baseline to Week 52 in 4-Item Composite Score of Niemann Pick Type C Severity Scale (NPC-SS) Score | Adrabetadex | Change from Baseline at Week 52 | 0.0 | Standard Deviation 2.45 | score on a scale |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Markedly improved (1) | 0 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Markedly improved (1) | 0 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Moderately improved (2) | 1 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Moderately improved (2) | 5 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Minimally improved (3) | 4 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Minimally improved (3) | 9 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Unchanged (4) | 9 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Unchanged (4) | 16 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Minimally worse (5) | 2 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Minimally worse (5) | 6 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Moderately worse (6) | 2 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Moderately worse (6) | 1 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Sham Control | Markedly worse (7) | 0 | Participants | |
| Parts A/B: Number of Participants Classified With Each Score on the Clinician Global Impression of Change (CGIC) at Week 52 | Adrabetadex | Markedly worse (7) | 1 | Participants | |
| Parts A/B: Change From Baseline to Week 52 in NPC-SS Total Score (Excluding Hearing and Auditory Brainstem Response [ABR]) | Sham Control | Baseline | 16.94 | Standard Deviation 8.164 | score on a scale |
| Parts A/B: Change From Baseline to Week 52 in NPC-SS Total Score (Excluding Hearing and Auditory Brainstem Response [ABR]) | Adrabetadex | Baseline | 17.81 | Standard Deviation 6.476 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02534844/results